Common Genetic Variants Explain 25-36% of Vulnerability to Drug Dependence
Common genetic variations accounted for 25-36% of the vulnerability to substance dependence across alcohol, tobacco, cannabis, cocaine, and other drugs, with genetic effects almost entirely shared across substances.
Quick Facts
What This Study Found
Researchers analyzed genetic data from 2,596 individuals in the Study of Addiction: Genetics and Environment to estimate how much common genetic variation contributes to drug dependence vulnerability.
Common single nucleotide polymorphisms (SNPs) explained 25-36% of the variance across three measures of drug problems. Drug dependence diagnoses and dependence vulnerability (ratio of symptoms to substances used) showed the largest genetic effects at 36% and 33% respectively.
Critically, the genetic effects were almost entirely shared across the three measures, with genetic correlations ranging from 0.92 to 0.97. This means the same genetic variants that contribute to cannabis dependence also contribute to alcohol, tobacco, and cocaine dependence.
Key Numbers
2,596 participants; SNP heritability: DD = 0.36, DV = 0.33, PU = 0.25; genetic correlations: 0.92-0.97 across measures; substances: alcohol, tobacco, cannabis, cocaine, other illicit drugs
How They Did This
Genome-wide complex trait analysis (GCTA) of 2,596 unrelated individuals. Three phenotypic measures: diagnostic drug dependence factor score, problem use factor score, and dependence vulnerability ratio. Univariate and bivariate analyses estimated SNP-based heritability and genetic covariance.
Why This Research Matters
This study addresses the "missing heritability" problem in addiction genetics. While individual genes have tiny effects, the aggregate contribution of common genetic variants is substantial, explaining up to a third of vulnerability to drug dependence.
The Bigger Picture
The finding that at least 25% of addiction vulnerability comes from common, measurable genetic variants could eventually enable genetic risk screening. The shared genetic architecture across substances reinforces that addiction is fundamentally one vulnerability expressed across different drugs.
What This Study Doesn't Tell Us
Selected sample from an addiction study may not represent the general population. GCTA provides aggregate estimates, not individual gene identification. Common SNPs only capture part of genetic variation. Environmental factors not fully accounted for.
Questions This Raises
- ?Can these aggregate genetic effects be used for clinical risk prediction?
- ?What specific biological pathways do these shared variants affect?
- ?Would genetic risk scores be useful for targeted prevention?
Trust & Context
- Key Stat:
- 25-36% of addiction vulnerability explained by common genetic variants
- Evidence Grade:
- Genome-wide analysis with appropriate methodology, though limited by selected sample and inability to identify specific causal variants.
- Study Age:
- Published in 2015. Genetic methods for studying addiction have continued to advance.
- Original Title:
- Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence.
- Published In:
- Addiction (Abingdon, England), 110(3), 530-7 (2015)
- Authors:
- Palmer, Rohan H C(2), Brick, Leslie, Nugent, Nicole R(2), Bidwell, L Cinnamon, McGeary, John E, Knopik, Valerie S, Keller, Matthew C
- Database ID:
- RTHC-01032
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Is addiction genetic?
This study found that common genetic variants explain 25-36% of the vulnerability to drug dependence. This means genetics play a significant role, but environment and other factors account for the majority of risk.
Are different addictions caused by the same genes?
Largely yes. The genetic correlations across different substance dependence measures were 0.92-0.97, meaning the genetic variants that increase risk for one addiction increase risk for virtually all of them.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
Cite This Study
https://rethinkthc.com/research/RTHC-01032APA
Palmer, Rohan H C; Brick, Leslie; Nugent, Nicole R; Bidwell, L Cinnamon; McGeary, John E; Knopik, Valerie S; Keller, Matthew C. (2015). Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence.. Addiction (Abingdon, England), 110(3), 530-7. https://doi.org/10.1111/add.12815
MLA
Palmer, Rohan H C, et al. "Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence.." Addiction (Abingdon, 2015. https://doi.org/10.1111/add.12815
RethinkTHC
RethinkTHC Research Database. "Examining the role of common genetic variants on alcohol, to..." RTHC-01032. Retrieved from https://rethinkthc.com/research/palmer-2015-examining-the-role-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.